PhRMA: WITHDRAW OR ABBREVIATE PART 11

The GMP Letter
A A

PhRMA is urging the FDA to withdraw or abbreviate its Part 11 regulation in favor of other more recently approved legislation dealing with the use of electronic records and signatures in day-to-day business, saying the rule is too prescriptive and the cost of compliance would be far too high.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $10.00